Stock Taper
IQVIA Holdings Inc. provides analytics, technology, and clinical research services to the global life sciences industry across three segments: Technology & Analytics, R&D Solutions, and Contract Sales & Medical Solutions.

IQVIA's AI-powered agents enhance the entire life sciences value chain, from R&D to commercialization, by leveraging healthcare data to drive innovation and efficiency in the industry.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Technology And Analytics Solutions | $1.63B | $3.45B ▲ | — | $3.55B ▲ |
![]() | Research And Development Solutions | $2.26B | $4.53B ▲ | $2.4B ▼ | $2.58B ▲ |
![]() | Contract Sales And Medical Solutions | $209M | $398M ▲ | — | — |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Americas | $1.93B | $4B ▲ | $1.98B ▼ | $2.04B ▲ |
![]() | EMEA | $1.3B | $2.66B ▲ | $1.35B ▼ | $1.41B ▲ |
![]() | Asia Pacific | $870M | $1.71B ▲ | $812M ▼ | $920M ▲ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
CAH | $247.18 | COMPARE |
HUM | $401.54 | COMPARE |
A | $150.84 | COMPARE |
HLN | $9.60 | COMPARE |
ALC | $70.50 | COMPARE |
RMD | $228.35 | COMPARE |
ILMN | $218.22 | COMPARE |
GEHC | $68.86 | COMPARE |